Trial Profile
TK-641 Phase 3 Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Jun 2016
Price :
$35
*
At a glance
- Drugs Oxycodone (Primary)
- Indications Cancer pain
- Focus Adverse reactions; Therapeutic Use
- Sponsors Teikoku Seiyaku
- 17 Jun 2016 New trial record